United Kingdom In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others.

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: April 30, 2020 Report Code: GDMEMC0512DB-ST

Select Item

GlobalData’s “United Kingdom In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United Kingdom In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health.

The United Kingdom In Vitro Diagnostics Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2018 company share and distribution share data for In Vitro Diagnostics Market.
• Global corporate-level profiles of key companies operating within the United Kingdom In Vitro Diagnostics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United Kingdom In Vitro Diagnostics Tests is segmented as follows:

• Cardiac Disease

• Clinical Chemistry

• Hematological Disorders

• Hormonal Disorder

• Infectious Disease

• IVD Analyzers and Reagents

• Metabolic Disorder

• Oncology

• Women's Health

Reasons to Buy

Key Reasons to Purchase – The United Kingdom In Vitro Diagnostics Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “United Kingdom In Vitro Diagnostics Market Outlook to 2025” report:
• F. Hoffmann-La Roche Ltd
• Danaher Corp
• Abbott Laboratories

Table

1.1 List of Tables

Table 1: In Vitro Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 52

Table 2: In Vitro Diagnostics Market, United Kingdom, Category Contribution by Revenue ($m), 2018 55

Table 3: In Vitro Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2015-2020 57

Table 4: In Vitro Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2021-2025 58

Table 5: In Vitro Diagnostics Market, United Kingdom, Volume (Units), 2015-2025 60

Table 6: In Vitro Diagnostics Market, United Kingdom, Volume (Units), Historic, 2015-2020 62

Table 7: In Vitro Diagnostics Market, United Kingdom, Volume (Units), Forecast, 2021-2025 63

Table 8: In Vitro Diagnostics Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2018 65

Table 9: Cardiac Disease Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 67

Table 10: Cardiac Disease Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 67

Table 11: Cardiac Marker Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 69

Table 12: Cardiac Marker Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 70

Table 13: Cardiac Disease Market, United Kingdom, Volume (Units), 2015-2020 72

Table 14: Cardiac Disease Market, United Kingdom, Volume (Units), 2021-2025 72

Table 15: Cardiac Marker Tests Market, United Kingdom, Volume (Units), 2015-2020 74

Table 16: Cardiac Marker Tests Market, United Kingdom, Volume (Units), 2021-2025 75

Table 17: Cardiac Disease Market, United Kingdom, Average Price ($), 2015-2020 76

Table 18: Cardiac Disease Market, United Kingdom, Average Price ($), 2021-2025 77

Table 19: Cardiac Disease Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2018 78

Table 20: Cardiac Disease Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2018 80

Table 21: Clinical Chemistry Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 82

Table 22: Clinical Chemistry Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 82

Table 23: Substrates Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 84

Table 24: Substrates Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 85

Table 25: Clinical Chemistry Market, United Kingdom, Volume (Units), 2015-2020 87

Table 26: Clinical Chemistry Market, United Kingdom, Volume (Units), 2021-2025 87

Table 27: Substrates Market, United Kingdom, Volume (Units), 2015-2020 89

Table 28: Substrates Market, United Kingdom, Volume (Units), 2021-2025 90

Table 29: Clinical Chemistry Market, United Kingdom, Average Price ($), 2015-2020 91

Table 30: Clinical Chemistry Market, United Kingdom, Average Price ($), 2021-2025 92

Table 31: Clinical Chemistry Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2018 93

Table 32: Clinical Chemistry Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2018 95

Table 33: Hematological Disorders Market, United Kingdom, Segment Contribution (%), 2018 97

Table 34: Hematological Disorders Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 99

Table 35: Hematological Disorders Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 99

Table 36: Hematology Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 101

Table 37: Hematology Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 102

Table 38: Hemostasis Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 104

Table 39: Hemostasis Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 105

Table 40: Hematological Disorders Market, United Kingdom, Volume (Units), 2015-2020 107

Table 41: Hematological Disorders Market, United Kingdom, Volume (Units), 2021-2025 107

Table 42: Hematology Tests Market, United Kingdom, Volume (Units), 2015-2020 109

Table 43: Hematology Tests Market, United Kingdom, Volume (Units), 2021-2025 110

Table 44: Hemostasis Tests Market, United Kingdom, Volume (Units), 2015-2020 112

Table 45: Hemostasis Tests Market, United Kingdom, Volume (Units), 2021-2025 113

Table 46: Hematological Disorders Market, United Kingdom, Average Price ($), 2015-2020 114

Table 47: Hematological Disorders Market, United Kingdom, Average Price ($), 2021-2025 116

Table 48: Hematological Disorders Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2018 118

Table 49: Hematological Disorders Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2018 120

Table 50: Hormonal Disorders Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 122

Table 51: Hormonal Disorders Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 122

Table 52: Thyroid Function Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 124

Table 53: Thyroid Function Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 125

Table 54: Hormonal Disorders Market, United Kingdom, Volume (Units), 2015-2020 127

Table 55: Hormonal Disorders Market, United Kingdom, Volume (Units), 2021-2025 127

Table 56: Thyroid Function Tests Market, United Kingdom, Volume (Units), 2015-2020 129

Table 57: Thyroid Function Tests Market, United Kingdom, Volume (Units), 2021-2025 130

Table 58: Hormonal Disorders Market, United Kingdom, Average Price ($), 2015-2020 131

Table 59: Hormonal Disorders Market, United Kingdom, Average Price ($), 2021-2025 132

Table 60: Hormonal Disorders Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2018 133

Table 61: Hormonal Disorders Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2018 135

Table 62: Infectious Disease Market, United Kingdom, Segment Contribution (%), 2018 138

Table 63: Infectious Disease Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 140

Table 64: Infectious Disease Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 141

Table 65: Chlamydia Trachomatis Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 143

Table 66: Chlamydia Trachomatis Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 143

Table 67: Clostridium difficile Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 145

Table 68: Clostridium difficile Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 146

Table 69: Cytomegalovirus (CMV) Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 148

Table 70: Cytomegalovirus (CMV) Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 148

Table 71: Hepatitis Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 150

Table 72: Hepatitis Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 150

Table 73: Human Immunodeficiency Virus (HIV) Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 152

Table 74: Human Immunodeficiency Virus (HIV) Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 153

Table 75: Human Papilloma Virus (HPV) Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 155

Table 76: Human Papilloma Virus (HPV) Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 155

Table 77: Human T-Lymphotropic Virus (HTLV) Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 157

Table 78: Human T-Lymphotropic Virus (HTLV) Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 157

Table 79: Mycobacterium Tuberculosis Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 159

Table 80: Mycobacterium Tuberculosis Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 159

Table 81: Neisseria Gonorrhoeae Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 161

Table 82: Neisseria Gonorrhoeae Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 161

Table 83: Treponema pallidum Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 163

Table 84: Treponema pallidum Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 164

Table 85: Infectious Disease Market, United Kingdom, Volume (Units), 2015-2020 166

Table 86: Infectious Disease Market, United Kingdom, Volume (Units), 2021-2025 168

Table 87: Chlamydia Trachomatis Tests Market, United Kingdom, Volume (Units), 2015-2020 171

Table 88: Chlamydia Trachomatis Tests Market, United Kingdom, Volume (Units), 2021-2025 171

Table 89: Clostridium difficile Tests Market, United Kingdom, Volume (Units), 2015-2020 173

Table 90: Clostridium difficile Tests Market, United Kingdom, Volume (Units), 2021-2025 174

Table 91: Cytomegalovirus (CMV) Tests Market, United Kingdom, Volume (Units), 2015-2020 176

Table 92: Cytomegalovirus (CMV) Tests Market, United Kingdom, Volume (Units), 2021-2025 176

Table 93: Hepatitis Tests Market, United Kingdom, Volume (Units), 2015-2020 178

Table 94: Hepatitis Tests Market, United Kingdom, Volume (Units), 2021-2025 178

Table 95: Human Immunodeficiency Virus (HIV) Tests Market, United Kingdom, Volume (Units), 2015-2020 180

Table 96: Human Immunodeficiency Virus (HIV) Tests Market, United Kingdom, Volume (Units), 2021-2025 181

Table 97: Human Papilloma Virus (HPV) Tests Market, United Kingdom, Volume (Units), 2015-2020 183

Table 98: Human Papilloma Virus (HPV) Tests Market, United Kingdom, Volume (Units), 2021-2025 183

Table 99: Human T-Lymphotropic Virus (HTLV) Tests Market, United Kingdom, Volume (Units), 2015-2020 185

Table 100: Human T-Lymphotropic Virus (HTLV) Tests Market, United Kingdom, Volume (Units), 2021-2025 185

Table 101: Mycobacterium Tuberculosis Tests Market, United Kingdom, Volume (Units), 2015-2020 187

Table 102: Mycobacterium Tuberculosis Tests Market, United Kingdom, Volume (Units), 2021-2025 187

Table 103: Neisseria Gonorrhoeae Tests Market, United Kingdom, Volume (Units), 2015-2020 189

Table 104: Neisseria Gonorrhoeae Tests Market, United Kingdom, Volume (Units), 2021-2025 189

Table 105: Treponema pallidum Tests Market, United Kingdom, Volume (Units), 2015-2020 191

Table 106: Treponema pallidum Tests Market, United Kingdom, Volume (Units), 2021-2025 192

Table 107: Infectious Disease Market, United Kingdom, Average Price ($), 2015-2020 193

Table 108: Infectious Disease Market, United Kingdom, Average Price ($), 2021-2025 196

Table 109: Infectious Disease Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2018 199

Table 110: Infectious Disease Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2018 201

Table 111: IVD Analyzers and Reagents Market, United Kingdom, Segment Contribution (%), 2018 203

Table 112: IVD Analyzers and Reagents Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 205

Table 113: IVD Analyzers and Reagents Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 206

Table 114: Clinical Chemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 208

Table 115: Clinical Chemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 208

Table 116: Hematology Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 210

Table 117: Hematology Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 211

Table 118: Immunochemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 213

Table 119: Immunochemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 214

Table 120: Polymerase Chain Reaction (PCR) Systems Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 216

Table 121: Polymerase Chain Reaction (PCR) Systems Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 217

Table 122: IVD Analyzers and Reagents Market, United Kingdom, Volume (Units), 2015-2020 219

Table 123: IVD Analyzers and Reagents Market, United Kingdom, Volume (Units), 2021-2025 220

Table 124: Clinical Chemistry Analyzers Market, United Kingdom, Volume (Units), 2015-2020 222

Table 125: Clinical Chemistry Analyzers Market, United Kingdom, Volume (Units), 2021-2025 222

Table 126: Hematology Analyzers Market, United Kingdom, Volume (Units), 2015-2020 224

Table 127: Hematology Analyzers Market, United Kingdom, Volume (Units), 2021-2025 225

Table 128: Immunochemistry Analyzers Market, United Kingdom, Volume (Units), 2015-2020 227

Table 129: Immunochemistry Analyzers Market, United Kingdom, Volume (Units), 2021-2025 228

Table 130: Polymerase Chain Reaction (PCR) Systems Market, United Kingdom, Volume (Units), 2015-2020 230

Table 131: Polymerase Chain Reaction (PCR) Systems Market, United Kingdom, Volume (Units), 2021-2025 231

Table 132: IVD Analyzers and Reagents Market, United Kingdom, Average Price ($), 2015-2020 232

Table 133: IVD Analyzers and Reagents Market, United Kingdom, Average Price ($), 2021-2025 234

Table 134: IVD Analyzers and Reagents Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2018 236

Table 135: IVD Analyzers and Reagents Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2018 238

Table 136: Metabolic Disorder Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 240

Table 137: Metabolic Disorder Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 240

Table 138: Diabetes Assays Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 242

Table 139: Diabetes Assays Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 243

Table 140: Metabolic Disorder Market, United Kingdom, Volume (Units), 2015-2020 245

Table 141: Metabolic Disorder Market, United Kingdom, Volume (Units), 2021-2025 245

Table 142: Diabetes Assays Market, United Kingdom, Volume (Units), 2015-2020 247

Table 143: Diabetes Assays Market, United Kingdom, Volume (Units), 2021-2025 248

Table 144: Metabolic Disorder Market, United Kingdom, Average Price ($), 2015-2020 249

Table 145: Metabolic Disorder Market, United Kingdom, Average Price ($), 2021-2025 250

Table 146: Metabolic Disorder Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2018 251

Table 147: Metabolic Disorder Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2018 253

Table 148: Oncology Market, United Kingdom, Segment Contribution (%), 2018 255

Table 149: Oncology Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 257

Table 150: Oncology Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 258

Table 151: ALK Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 260

Table 152: ALK Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 260

Table 153: BRCA Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 262

Table 154: BRCA Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 262

Table 155: Colorectal Cancer Screening Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 264

Table 156: Colorectal Cancer Screening Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 264

Table 157: EGFR Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 266

Table 158: EGFR Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 267

Table 159: HER2 Amplification Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 269

Table 160: HER2 Amplification Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 269

Table 161: KRAS Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 271

Table 162: KRAS Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 271

Table 163: Oncology Market, United Kingdom, Volume (Units), 2015-2020 273

Table 164: Oncology Market, United Kingdom, Volume (Units), 2021-2025 274

Table 165: ALK Tests Market, United Kingdom, Volume (Units), 2015-2020 276

Table 166: ALK Tests Market, United Kingdom, Volume (Units), 2021-2025 276

Table 167: BRCA Tests Market, United Kingdom, Volume (Units), 2015-2020 278

Table 168: BRCA Tests Market, United Kingdom, Volume (Units), 2021-2025 278

Table 169: Colorectal Cancer Screening Tests Market, United Kingdom, Volume (Units), 2015-2020 280

Table 170: Colorectal Cancer Screening Tests Market, United Kingdom, Volume (Units), 2021-2025 280

Table 171: EGFR Tests Market, United Kingdom, Volume (Units), 2015-2020 282

Table 172: EGFR Tests Market, United Kingdom, Volume (Units), 2021-2025 283

Table 173: HER2 Amplification Tests Market, United Kingdom, Volume (Units), 2015-2020 285

Table 174: HER2 Amplification Tests Market, United Kingdom, Volume (Units), 2021-2025 285

Table 175: KRAS Tests Market, United Kingdom, Volume (Units), 2015-2020 287

Table 176: KRAS Tests Market, United Kingdom, Volume (Units), 2021-2025 287

Table 177: Oncology Market, United Kingdom, Average Price ($), 2015-2020 288

Table 178: Oncology Market, United Kingdom, Average Price ($), 2021-2025 290

Table 179: Oncology Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2018 292

Table 180: Oncology Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2018 294

Table 181: Women's Health Market, United Kingdom, Segment Contribution (%), 2018 296

Table 182: Women's Health Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 298

Table 183: Women's Health Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 298

Table 184: Prenatal Screening Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 300

Table 185: Prenatal Screening Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 301

Table 186: Reproductive Hormones and Proteins Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020w 303

Table 187: Reproductive Hormones and Proteins Tests Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 304

Table 188: Women's Health Market, United Kingdom, Volume (Units), 2015-2020 306

Table 189: Women's Health Market, United Kingdom, Volume (Units), 2021-2025 306

Table 190: Prenatal Screening Market, United Kingdom, Volume (Units), 2015-2020 308

Table 191: Prenatal Screening Market, United Kingdom, Volume (Units), 2021-2025 309

Table 192: Reproductive Hormones and Proteins Tests Market, United Kingdom, Volume (Units), 2015-2020 311

Table 193: Reproductive Hormones and Proteins Tests Market, United Kingdom, Volume (Units), 2021-2025 312

Table 194: Women's Health Market, United Kingdom, Average Price ($), 2015-2020 313

Table 195: Women's Health Market, United Kingdom, Average Price ($), 2021-2025 315

Table 196: Women's Health Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2018 317

Table 197: Women's Health Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2018 319

Table 198: In Vitro Diagnostics Market Pipeline Products 324

Table 199: Recipharm to Acquire Consort Medical 328

Table 200: Abcam Acquires Expedeon, Innova Biosciences and TGR BioSciences from Expedeon for USD132.2 Million 331

Table 201: Braveheart Investment Acquires Remaining 43.5% Stake in Paraytec 334

Table 202: LifeSpan BioSciences Acquires Everest Biotech 335

Table 203: Eurobio Scientific Plans to Acquire Pathway Diagnostics and Personal Diagnostics from Vivo Medical Group 336

Table 204: Yourgene Health Acquires Elucigene 338

Table 205: Cambridge Pathology Acquires Clinical Lab Business from Novacyt for USD0.5 Million 340

Table 206: Vitrolife Acquires Business of Parallabs 342

Table 207: Quotient Raises USD96.6 Million in Public Offering of Shares 344

Table 208: Avacta Group to Raise up to USD11.5 Million in Private Placement of Shares 346

Table 209: Avacta Group to Raise USD0.04 Million in Rights Offering of Shares 348

Table 210: ValiRx Raises USD0.4 Million in Private Placement of Shares 350

Table 211: Tiziana Life Sciences to Raise Funds through Public Offering of ADS 351

Table 212: Renalytix AI to Raise USD14.98 Million in Private Placement of Shares 353

Table 213: ValiRx Terminates Private Placement of Securities for USD9.4 Million 354

Table 214: ANGLE Raises USD22.93 Million in Private Placement of Shares 356

Table 215: ValiRx Raises USD0.38 Million in Private Placement of Shares 357

Table 216: Safeguard Biosystems Holdings Raises USD3.5 Million in Equity Offering 358

Table 217: KwangDong Pharma Invests in Oxford Cancer Biomarkers 359

Table 218: Quotient to Raise up to USD80 Million in Public Offering of Shares 360

Table 219: Omega Diagnostics Raises USD0.8 Million in Private Placement of Shares 362

Table 220: Yourgene Health Raises USD14.8 Million in Private Placement of Shares 364

Table 221: Yourgene Health Raises USD0.7 Million in Rights Offering of Shares 366

Table 222: Novoheart Enters into Co-Development Partnership with Astrazeneca 368

Table 223: Fujirebio Europe Enters into Distribution Agreement with Atila Biosystems 369

Table 224: Owlstone Medical Enters into Partnership with Thermo Fisher Scientific 370

Table 225: QuantuMDx and SpeeDx Enter into Agreement with Foundation for Innovative New Diagnostics (FIND) 371

Table 226: Pillar Biosciences Enters into Co-Marketing Agreement with MGI Tech 372

Table 227: Sherlock Biosciences and Mologic Enter into Partnership 373

Table 228: Biodesix and Immodulon Therapeutics Enter into Research Collaboration 374

Table 229: Mirnax Biosens Enters into Licensing Agreement with Arcis Biotechnology 375

Table 230: Dongsung Pharma Enters into Licensing Agreement with Korea Electrotechnology Research Institute 376

Table 231: Medicines Discovery Catapult and LifeArc Enter into Agreement 377

Table 232: Andrew Alliance Enters into Co-Marketing Agreement with Arcis Biotechnology 378

Table 233: Abcam Enters into Agreement with NanoString Technologies 379

Table 234: Curetis and A. Menarini Diagnostics Enter into Distribution Partnership 380

Table 235: Horizon Discovery Enters into Collaboration with St George's University Hospital and European Molecular Genetics Quality Network (EMQN) 381

Table 236: KKR and Silvermill to Acquire Prometic Bioseparations from Liminal BioSciences 382

Table 237: Oxford Genetics Raises USD8.6 Million in Venture Financing 384

Table 238: Sense Biodetection Raises USD13.5 Million in Series A Financing 385

Table 239: Kheiron Medical Technologies Raises USD22 Million in Series A Financing 387

Table 240: Echopoint Medical Raises USD3.5 Million in Financing Round 389

Table 241: Biofidelity Raises USD1 Million in Seed Financing 390

Table 242: Kinomica Raises Funds through Financing 391

Table 243: Biosignatures Raises USD4.3 Million in Venture Financing 392

Table 244: Predictimmune Raises USD12.3 Million in Series B Financing 393

Table 245: ClinSpec Diagnostics Raises USD1.56 Million in Venture Financing 395

Table 246: Congenica Raises Additional USD17.1 Million in Series B Financing 396

Table 247: Sano Genetics Raises USD0.65 Million in Seed Financing 397

Table 248: Inivata Raises USD52.6 Million in Series B Financing 399

Table 249: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 680

Figures

1.2 List of Figures

Figure 1: In Vitro Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 51

Figure 2: In Vitro Diagnostics Market, United Kingdom, Revenue Mix ($m), 2018 53

Figure 3: In Vitro Diagnostics Market, United Kingdom, Category Contribution (%), 2018 54

Figure 4: In Vitro Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2015-2025 56

Figure 5: In Vitro Diagnostics Market, United Kingdom, Volume (Units), 2015-2025 59

Figure 6: In Vitro Diagnostics Market, United Kingdom, Volume (Units), Historic, 2015-2025 61

Figure 7: In Vitro Diagnostics Market, United Kingdom, Company Share (%) 2018 64

Figure 8: Cardiac Disease Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 66

Figure 9: Cardiac Marker Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 68

Figure 10: Cardiac Disease Market, United Kingdom, Volume (Units), 2015-2025 71

Figure 11: Cardiac Marker Tests Market, United Kingdom, Volume (Units), 2015-2025 73

Figure 12: Cardiac Disease Market, United Kingdom, Company Share (%) 2018 79

Figure 13: Clinical Chemistry Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 81

Figure 14: Substrates Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 83

Figure 15: Clinical Chemistry Market, United Kingdom, Volume (Units), 2015-2025 86

Figure 16: Substrates Market, United Kingdom, Volume (Units), 2015-2025 88

Figure 17: Clinical Chemistry Market, United Kingdom, Company Share (%) 2018 94

Figure 18: Hematological Disorders Market, United Kingdom, Revenue Mix ($m), 2018 96

Figure 19: Hematological Disorders Market, United Kingdom, Segment Contribution (%), 2018 97

Figure 20: Hematological Disorders Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 98

Figure 21: Hematology Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 100

Figure 22: Hemostasis Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 103

Figure 23: Hematological Disorders Market, United Kingdom, Volume (Units), 2015-2025 106

Figure 24: Hematology Tests Market, United Kingdom, Volume (Units), 2015-2025 108

Figure 25: Hemostasis Tests Market, United Kingdom, Volume (Units), 2015-2025 111

Figure 26: Hematological Disorders Market, United Kingdom, Company Share (%) 2018 119

Figure 27: Hormonal Disorders Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 121

Figure 28: Thyroid Function Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 123

Figure 29: Hormonal Disorders Market, United Kingdom, Volume (Units), 2015-2025 126

Figure 30: Thyroid Function Tests Market, United Kingdom, Volume (Units), 2015-2025 128

Figure 31: Hormonal Disorders Market, United Kingdom, Company Share (%) 2018 134

Figure 32: Infectious Disease Market, United Kingdom, Revenue Mix ($m), 2018 136

Figure 33: Infectious Disease Market, United Kingdom, Segment Contribution (%), 2018 137

Figure 34: Infectious Disease Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 139

Figure 35: Chlamydia Trachomatis Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 142

Figure 36: Clostridium difficile Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 144

Figure 37: Cytomegalovirus (CMV) Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 147

Figure 38: Hepatitis Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 149

Figure 39: Human Immunodeficiency Virus (HIV) Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 151

Figure 40: Human Papilloma Virus (HPV) Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 154

Figure 41: Human T-Lymphotropic Virus (HTLV) Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 156

Figure 42: Mycobacterium Tuberculosis Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 158

Figure 43: Neisseria Gonorrhoeae Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 160

Figure 44: Treponema pallidum Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 162

Figure 45: Infectious Disease Market, United Kingdom, Volume (Units), 2015-2025 165

Figure 46: Chlamydia Trachomatis Tests Market, United Kingdom, Volume (Units), 2015-2025 170

Figure 47: Clostridium difficile Tests Market, United Kingdom, Volume (Units), 2015-2025 172

Figure 48: Cytomegalovirus (CMV) Tests Market, United Kingdom, Volume (Units), 2015-2025 175

Figure 49: Hepatitis Tests Market, United Kingdom, Volume (Units), 2015-2025 177

Figure 50: Human Immunodeficiency Virus (HIV) Tests Market, United Kingdom, Volume (Units), 2015-2025 179

Figure 51: Human Papilloma Virus (HPV) Tests Market, United Kingdom, Volume (Units), 2015-2025 182

Figure 52: Human T-Lymphotropic Virus (HTLV) Tests Market, United Kingdom, Volume (Units), 2015-2025 184

Figure 53: Mycobacterium Tuberculosis Tests Market, United Kingdom, Volume (Units), 2015-2025 186

Figure 54: Neisseria Gonorrhoeae Tests Market, United Kingdom, Volume (Units), 2015-2025 188

Figure 55: Treponema pallidum Tests Market, United Kingdom, Volume (Units), 2015-2025 190

Figure 56: Infectious Disease Market, United Kingdom, Company Share (%) 2018 200

Figure 57: IVD Analyzers and Reagents Market, United Kingdom, Revenue Mix ($m), 2018 202

Figure 58: IVD Analyzers and Reagents Market, United Kingdom, Segment Contribution (%), 2018 203

Figure 59: IVD Analyzers and Reagents Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 204

Figure 60: Clinical Chemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 207

Figure 61: Hematology Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 209

Figure 62: Immunochemistry Analyzers Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 212

Figure 63: Polymerase Chain Reaction (PCR) Systems Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 215

Figure 64: IVD Analyzers and Reagents Market, United Kingdom, Volume (Units), 2015-2025 218

Figure 65: Clinical Chemistry Analyzers Market, United Kingdom, Volume (Units), 2015-2025 221

Figure 66: Hematology Analyzers Market, United Kingdom, Volume (Units), 2015-2025 223

Figure 67: Immunochemistry Analyzers Market, United Kingdom, Volume (Units), 2015-2025 226

Figure 68: Polymerase Chain Reaction (PCR) Systems Market, United Kingdom, Volume (Units), 2015-2025 229

Figure 69: IVD Analyzers and Reagents Market, United Kingdom, Company Share (%) 2018 237

Figure 70: Metabolic Disorder Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 239

Figure 71: Diabetes Assays Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 241

Figure 72: Metabolic Disorder Market, United Kingdom, Volume (Units), 2015-2025 244

Figure 73: Diabetes Assays Market, United Kingdom, Volume (Units), 2015-2025 246

Figure 74: Metabolic Disorder Market, United Kingdom, Company Share (%) 2018 252

Figure 75: Oncology Market, United Kingdom, Revenue Mix ($m), 2018 254

Figure 76: Oncology Market, United Kingdom, Segment Contribution (%), 2018 255

Figure 77: Oncology Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 256

Figure 78: ALK Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 259

Figure 79: BRCA Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 261

Figure 80: Colorectal Cancer Screening Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 263

Figure 81: EGFR Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 265

Figure 82: HER2 Amplification Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 268

Figure 83: KRAS Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 270

Figure 84: Oncology Market, United Kingdom, Volume (Units), 2015-2025 272

Figure 85: ALK Tests Market, United Kingdom, Volume (Units), 2015-2025 275

Figure 86: BRCA Tests Market, United Kingdom, Volume (Units), 2015-2025 277

Figure 87: Colorectal Cancer Screening Tests Market, United Kingdom, Volume (Units), 2015-2025 279

Figure 88: EGFR Tests Market, United Kingdom, Volume (Units), 2015-2025 281

Figure 89: HER2 Amplification Tests Market, United Kingdom, Volume (Units), 2015-2025 284

Figure 90: KRAS Tests Market, United Kingdom, Volume (Units), 2015-2025 286

Figure 91: Oncology Market, United Kingdom, Company Share (%) 2018 293

Figure 92: Women's Health Market, United Kingdom, Revenue Mix ($m), 2018 295

Figure 93: Women's Health Market, United Kingdom, Segment Contribution (%), 2018 296

Figure 94: Women's Health Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 297

Figure 95: Prenatal Screening Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 299

Figure 96: Reproductive Hormones and Proteins Tests Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 302

Figure 97: Women's Health Market, United Kingdom, Volume (Units), 2015-2025 305

Figure 98: Prenatal Screening Market, United Kingdom, Volume (Units), 2015-2025 307

Figure 99: Reproductive Hormones and Proteins Tests Market, United Kingdom, Volume (Units), 2015-2025 310

Figure 100: Women's Health Market, United Kingdom, Company Share (%) 2018 318

Frequently asked questions

United Kingdom In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others. standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United Kingdom In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others. in real time.

  • Access a live United Kingdom In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others. dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more